• Je něco špatně v tomto záznamu ?

Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy

M. Dvela-Levitt, M. Kost-Alimova, M. Emani, E. Kohnert, R. Thompson, EH. Sidhom, A. Rivadeneira, N. Sahakian, J. Roignot, G. Papagregoriou, MS. Montesinos, AR. Clark, D. McKinney, J. Gutierrez, M. Roth, L. Ronco, E. Elonga, TA. Carter, A. Gnirke,...

. 2019 ; 178 (3) : 521-535.e23. [pub] 20190725

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023811

Grantová podpora
NV17-29786A MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek

E-zdroje Online Plný text

NLK Cell Press Free Archives od 1995-01-01 do Před 1 rokem
Free Medical Journals od 1995 do Před 1 rokem
Open Access Digital Library od 1995-01-01
Elsevier Open Access Journals od 1995-01-13 do 2023-06-22
Elsevier Open Archive Journals od 1995-01-13 do Před 1 rokem

Odkazy

PubMed 31348885
DOI 10.1016/j.cell.2019.07.002
Knihovny.cz E-zdroje

Intracellular accumulation of misfolded proteins causes toxic proteinopathies, diseases without targeted therapies. Mucin 1 kidney disease (MKD) results from a frameshift mutation in the MUC1 gene (MUC1-fs). Here, we show that MKD is a toxic proteinopathy. Intracellular MUC1-fs accumulation activated the ATF6 unfolded protein response (UPR) branch. We identified BRD4780, a small molecule that clears MUC1-fs from patient cells, from kidneys of knockin mice and from patient kidney organoids. MUC1-fs is trapped in TMED9 cargo receptor-containing vesicles of the early secretory pathway. BRD4780 binds TMED9, releases MUC1-fs, and re-routes it for lysosomal degradation, an effect phenocopied by TMED9 deletion. Our findings reveal BRD4780 as a promising lead for the treatment of MKD and other toxic proteinopathies. Generally, we elucidate a novel mechanism for the entrapment of misfolded proteins by cargo receptors and a strategy for their release and anterograde trafficking to the lysosome.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023811
003      
CZ-PrNML
005      
20201214131303.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.cell.2019.07.002 $2 doi
035    __
$a (PubMed)31348885
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dvela-Levitt, Moran $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
245    10
$a Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy / $c M. Dvela-Levitt, M. Kost-Alimova, M. Emani, E. Kohnert, R. Thompson, EH. Sidhom, A. Rivadeneira, N. Sahakian, J. Roignot, G. Papagregoriou, MS. Montesinos, AR. Clark, D. McKinney, J. Gutierrez, M. Roth, L. Ronco, E. Elonga, TA. Carter, A. Gnirke, M. Melanson, K. Hartland, N. Wieder, JC. Hsu, C. Deltas, R. Hughey, AJ. Bleyer, S. Kmoch, M. Živná, V. Barešova, S. Kota, J. Schlondorff, M. Heiman, SL. Alper, F. Wagner, A. Weins, TR. Golub, ES. Lander, A. Greka,
520    9_
$a Intracellular accumulation of misfolded proteins causes toxic proteinopathies, diseases without targeted therapies. Mucin 1 kidney disease (MKD) results from a frameshift mutation in the MUC1 gene (MUC1-fs). Here, we show that MKD is a toxic proteinopathy. Intracellular MUC1-fs accumulation activated the ATF6 unfolded protein response (UPR) branch. We identified BRD4780, a small molecule that clears MUC1-fs from patient cells, from kidneys of knockin mice and from patient kidney organoids. MUC1-fs is trapped in TMED9 cargo receptor-containing vesicles of the early secretory pathway. BRD4780 binds TMED9, releases MUC1-fs, and re-routes it for lysosomal degradation, an effect phenocopied by TMED9 deletion. Our findings reveal BRD4780 as a promising lead for the treatment of MKD and other toxic proteinopathies. Generally, we elucidate a novel mechanism for the entrapment of misfolded proteins by cargo receptors and a strategy for their release and anterograde trafficking to the lysosome.
650    _2
$a transkripční faktor ATF6 $x metabolismus $7 D051702
650    _2
$a zvířata $7 D000818
650    _2
$a benzamidy $x chemie $x metabolismus $x farmakologie $7 D001549
650    _2
$a epitelové buňky $x cytologie $x metabolismus $7 D004847
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a posunová mutace $7 D016368
650    _2
$a lidé $7 D006801
650    _2
$a imidazolinové receptory $x antagonisté a inhibitory $x genetika $x metabolismus $7 D054755
650    _2
$a indukované pluripotentní kmenové buňky $x cytologie $x metabolismus $7 D057026
650    _2
$a ledviny $x cytologie $x metabolismus $x patologie $7 D007668
650    _2
$a nemoci ledvin $x metabolismus $x patologie $7 D007674
650    _2
$a lyzozomy $x metabolismus $7 D008247
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši transgenní $7 D008822
650    _2
$a mucin 1 $x chemie $x genetika $x metabolismus $7 D018396
650    _2
$a RNA interference $7 D034622
650    _2
$a malá interferující RNA $x metabolismus $7 D034741
650    _2
$a signální dráha UPR $x účinky léků $7 D056811
650    _2
$a vezikulární transportní proteiny $x chemie $x metabolismus $7 D033921
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kost-Alimova, Maria $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Emani, Maheswarareddy $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a Kohnert, Eva $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a Thompson, Rebecca $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a Sidhom, Eriene-Heidi $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a Rivadeneira, Ana $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a Sahakian, Nareh $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a Roignot, Julie $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a Papagregoriou, Gregory $u Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological Sciences, University of Cyprus, Nicosia, Cyprus.
700    1_
$a Montesinos, Monica S $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a Clark, Abbe R $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a McKinney, David $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Gutierrez, Juan $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Roth, Mark $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Ronco, Lucienne $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Elonga, Esther $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Carter, Todd A $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Gnirke, Andreas $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Melanson, Michelle $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Hartland, Kate $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Wieder, Nicolas $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
700    1_
$a Hsu, Jane C-H $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Deltas, Constantinos $u Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological Sciences, University of Cyprus, Nicosia, Cyprus.
700    1_
$a Hughey, Rebecca $u Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
700    1_
$a Bleyer, Anthony J $u Section on Nephrology, Wake Forest School of Medicine, Medical Center Blvd., Winston-Salem, NC, USA; Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Kmoch, Stanislav $u Section on Nephrology, Wake Forest School of Medicine, Medical Center Blvd., Winston-Salem, NC, USA; Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Živná, Martina $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Barešova, Veronika $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Kota, Savithri $u Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
700    1_
$a Schlondorff, Johannes $u Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
700    1_
$a Heiman, Myriam $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; The Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, MIT, Cambridge, MA, USA.
700    1_
$a Alper, Seth L $u Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
700    1_
$a Wagner, Florence $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Weins, Astrid $u Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
700    1_
$a Golub, Todd R $u Broad Institute of MIT and Harvard, Cambridge, MA, USA.
700    1_
$a Lander, Eric S $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Biology, MIT, Cambridge, MA, USA; Department of Systems Biology, Harvard Medical School, Boston, MA, USA.
700    1_
$a Greka, Anna $u Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: agreka@broadinstitute.org.
773    0_
$w MED00009444 $t Cell $x 1097-4172 $g Roč. 178, č. 3 (2019), s. 521-535.e23
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31348885 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214131300 $b ABA008
999    __
$a ok $b bmc $g 1596130 $s 1114487
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 178 $c 3 $d 521-535.e23 $e 20190725 $i 1097-4172 $m Cell $n Cell $x MED00009444
GRA    __
$a NV17-29786A $p MZ0
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

    Možnosti archivace